PhotoCure appoints Kjetil Hestdal as new President and CEO
Kjetil Hestdal, MD, PhD, has worked at PhotoCure since 1997, as Vice President R&D and more recently as Chief Operating Officer. Over the years he has lead the development of two pharmaceutical products MetvixÒ and HexvixÒ. Kjetil Hestdal has broad international experience in the pharmaceutical industry and spent 5 years developing pharmaceutical products at Norvartis.
Erik Engebretsen, Chairman of the Board of PhotoCure ASA comments: "The Board thank Vidar Hansson for his dedication to PhotoCure in the last 8 years, and for having developed two pharmaceutical products with large market potential. The Board is pleased that it has been able to recruit the new CEO from within the company, and strongly believe that Kjetil Hestdal will further develop PhotoCure as a commercial pharmaceutical company with increasing international sales and the ability to develop new products."
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.